The mission of the PRCSG is to conduct high quality clinical trials, of therapeutic agents, in children with rheumatic diseases.
Joined April 2022
- Tweets77
- Following93
- Followers91
- Likes8
Spotlight on Our Research: Abstract presentation at ACR Convergence 2026
Long-Term Efficacy of Upadacitinib in Patients: Insights from SELECT-YOUTH Trial
Pediatric Rheumatology-Clinical: JIA (1826-1831)
Abstract Session, Monday, November 9, 2026, 8:30AM-8:45AM
4
Explore Our Latest Research at ACR Convergence 2026.
Long-term safety and efficacy of tofacitinib . . . final results of an open-label extension study
Session: Pediatric Rheumatology - Clinical Poster C
Date: Tuesday November 10, 2026
Presentation Time: 10:30 AM - 12:30 PM
8
See Our Research in Action at ACR Convergence 2026
Efficacy and Safety of Subcutaneous Ustekinumab, Phase 3 PSUMMIT-Jr Study Through Week 52
Monday, November 9, 2026
10:30 AM – 12:30 PM, Poster 1505
19
PRCSG - 50 Years of Pediatric Rheumatology Research youtu.be/XHhvE2tX0pI?si=vbUD… via @YouTube
Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+‐year results from a multicenter, open‐label study - Brunner - Arthritis & Rheumatology - Wiley Online Library acrjournals.onlinelibrary.wi…
36
Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient‐Reported Outcomes in a Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Withdrawal Trial - Brunner - 2026 - Arthritis & Rheumatology - Wiley Online Library acrjournals.onlinelibrary.wi…
1
15
Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial - Brunner - Arthritis Care & Research - Wiley Online Library acrjournals.onlinelibrary.wi…
9
PRCSG_network retweeted
🎄 Lace up & save! The Jingle Bell Run is coming, and now’s your chance to join in for less. Use code FALL for $5 off registration — limited time only! 🏃♀️❄️
Run for fun. Run for a cause. 👉 arthr.org/4lT6Cy2
#JingleBellRun
"Juvenile Spondyloarthritis Disease Activity Index Validation in Enthesitis-Related Arthritis and Juvenile Psoriatic Arthritis in a Prospective Clinical Trial Setting" — Read it on @ResearchGate: researchgate.net/publication…
11
25 Years of Biologics for the Treatment of Pediatric Rheumatic Disease: Advances in Prognosis and Ongoing Challenges - Shishov - 2025 - Arthritis Care & Research - Wiley Online Library acrjournals.onlinelibrary.wi…
1
13
Clinically Inactive Disease and Remission in Patients with Juvenile Idiopathic Arthritis Receiving Tofacitinib: Pos… pubmed.ncbi.nlm.nih.gov/4031…
17
Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations… pubmed.ncbi.nlm.nih.gov/3995…
17
Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular-Course Juvenile Idiopathic Ar… pubmed.ncbi.nlm.nih.gov/3913…
15
Efficacy and Safety of Tofacitinib in Patients with Active Systemic Juvenile Idiopathic Arthritis acrabstracts.org/abstract/ef…
17
Pharmacokinetics of Ustekinumab in Patients with Juvenile Psoriatic Arthritis in a Real‑World Opportunistic Study acrabstracts.org/abstract/ph…
15
Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients with Polyarticular‐Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open‐label, Phase 1 Trial - Brunner - Arthritis Care & Research - Wiley Online Library acrjournals.onlinelibrary.wi…
22
Transcriptional Profiling of Tofacitinib Treatment in Juvenile Idiopathic Arthritis: Implications for Treatment Response Prediction - Eloseily - Arthritis Care & Research - Wiley Online Library acrjournals.onlinelibrary.wi…
27
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study jrheum.org/content/51/11/112…
S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthrit… pubmed.ncbi.nlm.nih.gov/3891…
16